Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Financial information
Financial calender
Don't miss out on any important happenings,
See coming publications below.
Bokslutskommuniké 2022 25/1 2023
Årsredovisning 2022 Vecka 16 2023
Delårsrapport Q1 25/4 2023
Årsstämma 31/5 2023
Delårsrapport Q2 22/8 2023
Delårsrapport Q3 24/10 2023
Bokslutskommuniké 2023 24/1 2024
Reports
Only available in Swedish
Annual reports
Only available in Swedish
Board and Article of association
Board
_edited.png)
Peter Wendel
Chairman
Peter Wendel has long and solid experience from entrepreneurship in software development and other parts of the tech industry. Peter also has experience of board work in listed companies, including as chairman of the board of Appspotr (listed on the Nasdaq First North Growth Market).
Martin King
Independent board member
Martin King, a British/Swiss national, brings over 40 years of extensive global experience in quality assurance, regulatory affairs, operational management, and leadership. With an educational background in Electronics, Software as a Medical Device, Mechanical Engineering, and Materials Science, Martin has worked across the complete value-chain of the Medical Device, In Vitro Diagnostics, and Pharmaceutical industry. As an independent consultant, Martin helps companies successfully approve their products and maximize their businesses by applying quality assurance and regulatory affairs throughout the product life-cycle.
Hans-Peter Ostler
Board member
Hans-Peter has more than 20 years of experience from investment and private banking in Swedbank, UBS, Danske Bank and Söderberg & Partners combined with experience of board work, in both listed and unlisted companies, mainly in innovation-driven activities such as Life Science, Tech and Greentech.
